Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.44 USD | +0.21% | +0.89% | +123.20% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Fusion Pharmaceuticals : Morgan Stanley Adjusts Price Target on Fusion Pharmaceuticals to $19 From $20, Maintains Overweight Rating